Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Elena Vega

Medicare's New GLP-1 Weight Loss Drug Program Launched July 1, but It Expires in 2027 with No Successor in Place

Why This Matters

For the first time in Medicare's history, eligible beneficiaries can access GLP-1 weight-loss drugs through the federal program that insures more than 67 million Americans. The Medicare GLP-1 Bridge Program launched July 1, 2026, charging eligible Part D enrollees a flat $50 per month co-pay for certain GLP-1 medications prescribed for obesity.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.